Effect of leuprorelin in  bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year

ConclusionsLeuprorelin significantly reduced the pharyngeal residue in patients with SBMA after 1 year of treatment without any serious adverse events and longitudinal studies are needed to confirm these results.

Source: Journal of Neurology - March 6, 2021 Category: Neurology Source Type: research